177 related articles for article (PubMed ID: 27865966)
1. Febuxostat attenuates paroxysmal atrial fibrillation-induced regional endothelial dysfunction.
Li Y; Chen F; Deng L; Lin K; Shi X; Zhaoliang S; Wang Y
Thromb Res; 2017 Jan; 149():17-24. PubMed ID: 27865966
[TBL] [Abstract][Full Text] [Related]
2. Antiremodeling Effect of Xanthine Oxidase Inhibition in a Canine Model of Atrial Fibrillation.
Yoshizawa T; Niwano S; Niwano H; Tamaki H; Nakamura H; Igarashi T; Oikawa J; Satoh A; Kishihara J; Murakami M; Fukaya H; Ako J
Int Heart J; 2018 Sep; 59(5):1077-1085. PubMed ID: 30158379
[TBL] [Abstract][Full Text] [Related]
3. Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats.
Shirakura T; Nomura J; Matsui C; Kobayashi T; Tamura M; Masuzaki H
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):831-8. PubMed ID: 27198514
[TBL] [Abstract][Full Text] [Related]
4. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
[TBL] [Abstract][Full Text] [Related]
5. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
Lim HS; Willoughby SR; Schultz C; Gan C; Alasady M; Lau DH; Leong DP; Brooks AG; Young GD; Kistler PM; Kalman JM; Worthley MI; Sanders P
J Am Coll Cardiol; 2013 Feb; 61(8):852-60. PubMed ID: 23333141
[TBL] [Abstract][Full Text] [Related]
6. Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
Xu D; Murakoshi N; Tajiri K; Duo F; Okabe Y; Murakata Y; Yuan Z; Li S; Aonuma K; Song Z; Shimoda Y; Mori H; Sato A; Nogami A; Aonuma K; Ieda M
Clin Sci (Lond); 2021 Oct; 135(20):2409-2422. PubMed ID: 34386810
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
[TBL] [Abstract][Full Text] [Related]
8. Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: a randomized, placebo-controlled, double-blinded study.
Alshahawey M; Shaheen SM; Elsaid T; Sabri NA
Int Urol Nephrol; 2019 Sep; 51(9):1649-1657. PubMed ID: 31368057
[TBL] [Abstract][Full Text] [Related]
9. Effects of febuxostat on atrial remodeling in a rabbit model of atrial fibrillation induced by rapid atrial pacing.
Fan YY; Xu F; Zhu C; Cheng WK; Li J; Shan ZL; Li Y; Wang YT
J Geriatr Cardiol; 2019 Jul; 16(7):540-551. PubMed ID: 31447893
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases.
Dudley SC; Hoch NE; McCann LA; Honeycutt C; Diamandopoulos L; Fukai T; Harrison DG; Dikalov SI; Langberg J
Circulation; 2005 Aug; 112(9):1266-73. PubMed ID: 16129811
[TBL] [Abstract][Full Text] [Related]
11. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
[TBL] [Abstract][Full Text] [Related]
12. Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress-Mediated Atrial Remodeling in Alloxan-Induced Diabetes Mellitus Rabbits.
Yang Y; Zhao J; Qiu J; Li J; Liang X; Zhang Z; Zhang X; Fu H; Korantzopoulos P; Letsas KP; Tse G; Li G; Liu T
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720500
[TBL] [Abstract][Full Text] [Related]
13. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Zhao L; Roche BM; Wessale JL; Kijtawornrat A; Lolly JL; Shemanski D; Hamlin RL
Life Sci; 2008 Feb; 82(9-10):495-502. PubMed ID: 18215719
[TBL] [Abstract][Full Text] [Related]
14. Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
Alshahawey M; Shahin SM; Elsaid TW; Sabri NA
Am J Nephrol; 2017; 45(5):452-459. PubMed ID: 28463849
[TBL] [Abstract][Full Text] [Related]
15. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622
[TBL] [Abstract][Full Text] [Related]
16. PTEN/PI3K/VEGF signaling pathway involved in the protective effect of xanthine oxidase inhibitor febuxostat against endometrial hyperplasia in rats.
Mohamed MZ; Baky MAE; Hassan OA; Mohammed HH; Abdel-Aziz AM
Hum Exp Toxicol; 2020 Sep; 39(9):1224-1234. PubMed ID: 32228192
[TBL] [Abstract][Full Text] [Related]
17. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress.
Tsuda H; Kawada N; Kaimori JY; Kitamura H; Moriyama T; Rakugi H; Takahara S; Isaka Y
Biochem Biophys Res Commun; 2012 Oct; 427(2):266-72. PubMed ID: 22995295
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation.
Sabán-Ruiz J; Alonso-Pacho A; Fabregate-Fuente M; de la Puerta González-Quevedo C
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):94-9. PubMed ID: 23286293
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart.
Duda M; Konior A; Klemenska E; Beresewicz A
J Mol Cell Cardiol; 2007 Feb; 42(2):400-10. PubMed ID: 17156794
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Xanthine Oxidase Protects against Diabetic Kidney Disease through the Amelioration of Oxidative Stress via VEGF/VEGFR Axis and NOX-FoxO3a-eNOS Signaling Pathway.
Yang KJ; Choi WJ; Chang YK; Park CW; Kim SY; Hong YA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
